** = Publikationen gelistet in SCI/SSCI/Pubmed
** Graier, T; Salmhofer, W; Jonak, C; Weger, W; Kölli, C; Gruber, B; Sator, PG; Prillinger, K; Mlynek, A; Schütz-Bergmayr, M; Richter, L; Ratzinger, G; Painsi, C; Selhofer, S; Häring, N; Wippel-Slupetzky, K; Skvara, H; Trattner, H; Tanew, A; Inzinger, M; Tatarski, R; Bangert, C; Ellersdorfer, C; Lichem, R; Gruber-Wackernagel, A; Hofer, A; Legat, F; Schmiedberger, E; Strohal, R; Lange-Asschenfeldt, B; Schmuth, M; Vujic, I; Hoetzenecker, W; Trautinger, F; Saxinger, W; Müllegger, R; Quehenberger, F; Wolf, P
Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis.
Br J Dermatol. 2021; 184(6):1094-1105
Doi: 10.1111/bjd.19701
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Graier, T; Weger, W; Sator, PG; Salmhofer, W; Gruber, B; Jonak, C; Kölli, C; Schütz-Bergmayr, M; Vujic, I; Ratzinger, G; Häring, N; Painsi, C; Prillinger, K; Mlynek, A; Skvara, H; Trattner, H; Tanew, A; Lichem, R; Ellersdorfer, C; Legat, F; Gruber-Wackernagel, A; Hofer, A; Schmiedberger, E; Hoetzenecker, W; Müllegger, R; Saxinger, W; Quehenberger, F; Wolf, P
Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis.
JAAD Int. 2021; 2: 62-75.
Doi: 10.1016/j.jdin.2020.10.012
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kohlmaier, B; Schweintzger, NA; Sagmeister, MG; Švendová, V; Kohlfürst, DS; Sonnleitner, A; Leitner, M; Berghold, A; Schmiedberger, E; Fazekas, F; Pichler, A; Rejc-Marko, J; Růžek, D; Dufková, L; Čejková, D; Husa, P; Pýchová, M; Krbková, L; Chmelík, V; Štruncová, V; Zavadska, D; Karelis, G; Mickiene, A; Zajkowska, J; Bogovič, P; Strle, F; Zenz, W; The, Eu-Tick-Bo, Study
Clinical Characteristics of Patients with Tick-Borne Encephalitis (TBE): A European Multicentre Study from 2010 to 2017.
Microorganisms. 2021; 9(7):
Doi: 10.3390/microorganisms9071420
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG